Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02705196
Title LOAd703 Oncolytic Virus Therapy for Pancreatic Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Lokon Pharma AB
Indications

pancreatic ductal adenocarcinoma

Therapies

Atezolizumab + Gemcitabine + LOAd703 + Nab-paclitaxel

Gemcitabine + LOAd703 + Nab-paclitaxel

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.